Table S14 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

<p>Clinical, pathological and genomic features for Tier 2 borderline conventional tumors with high probability of melanoma. Additional ancillary test results are included when available from the patients’ report. Catalogue of Somatic Mutations in Cancer (COSMIC) identifiers for coding mutations are included.</p>